Pedro Paulo Teixeira e Silva Torres

Dr. Pedro Paulo Teixeira e Silva Torres

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2021 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PTPedro Paulo Teixeira e Silva Torres
Pedro Paulo Teixeira e Silva Torres
MRMarcelo Fouad Rabahi
Marcelo Fouad Rabahi
MMMaria Auxiliadora do Carmo Moreira
Maria Auxiliadora do Carmo Moreira
DEDante Luiz Escuissato
Dante Luiz Escuissato
GMGustavo de Souza Portes Meirelles
Gustavo de Souza Portes Meirelles
EMEdson Santos Marchiori
Edson Santos Marchiori
Many conditions result in chronic interstitial lung disease (ILD), being classified as fibrosing ILDs, including idiopathic pulmonary fibrosis, connective tissue diseases, sarcoidosis, and fibrotic hypersensitivity pneumonitis. HRCT plays an important role in the clinical evaluation of fibrosing ILDs. Current treatment perspectives are encouraging and reinforce the need for HRCT scans of adequate technical quality for early detection of fibrosing ILD. Despite efforts in this regard, the significance and management of imaging findings of early interstitial lung abnormalities have yet to be clarified. After identification of CT findings consistent with fibrosing ILD, radiologists must be able to identify characteristic morphological patterns and, in some cases, features of specific clinical entities. In cases in which HRCT features are not sufficiently specific for a definitive diagnosis, HRCT can aid in selecting the best site for surgical lung biopsy. CT follow-up is useful for identifying progressive fibrosing ILDs and detecting complications unrelated to the underlying disease, including infections, acute exacerbations, and neoplasms. Automated quantification tools have clinical applicability and are likely to be available for use in imaging analysis in the near future. In addition, incorporation of CT evaluation into scoring systems based on clinical and functional parameters for staging fibrosing disease is likely to become valuable in determining prognosis. Knowledge of the clinical applications of CT evaluation is essential for specialists managing patients with fibrosing ILD and can have a positive impact on the clinical course of the disease.

1 December 2017 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
HFHeloisa Maria Pereira Freitas
Heloisa Maria Pereira Freitas
AMAlexandre Dias Mançano
Alexandre Dias Mançano
RRRosana Souza Rodrigues
Rosana Souza Rodrigues
BHBruno Hochhegger
Bruno Hochhegger
PTPedro Paulo Teixeira e Silva Torres
Pedro Paulo Teixeira e Silva Torres
EMEdson Santos Marchiori
Edson Santos Marchiori
Objective: To analyze HRCT findings in patients with Niemann-Pick disease (NPD) type B, in order to determine the frequency of HRCT patterns and their distribution in the lung parenchyma, as well as the most common clinical characteristics. Methods: We studied 13 patients (3 males and 10 females) aged 5 to 56 years. HRCT images were independently evaluated by two observers, and disagreements were resolved by consensus. The inclusion criteria were presence of abnormal HRCT findings and diagnosis of NPD type B confirmed by histopathological examination of a bone marrow, lung, or liver biopsy specimen. Results: The most common clinical findings were hepatosplenomegaly and mild to moderate dyspnea. The most common HRCT patterns were smooth interlobular septal thickening and ground-glass opacities, which were both present in all patients. Intralobular lines were present in 12 patients (92.3%). A crazy-paving pattern was observed in 5 patients (38.4%), and areas of air trapping were identified in only 1 case (7.6%). Pulmonary involvement was bilateral in all cases, with the most affected area being the lower lung zone. Conclusions: Smooth interlobular septal thickening, with or without associated ground-glass opacities, in patients with hepatosplenomegaly is the most common finding in NPD type B.

1 April 2013 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
MMMaria Auxiliadora Carmo Moreira
Maria Auxiliadora Carmo Moreira
MBMaria Alves Barbosa
Maria Alves Barbosa
MQMaria Conceição de Castro Antonelli Monteiro de Queiroz
Maria Conceição de Castro Antonelli Monteiro de Queiroz
KTKim Ir Sen Santos Teixeira
Kim Ir Sen Santos Teixeira
PTPedro Paulo Teixeira e Silva Torres
Pedro Paulo Teixeira e Silva Torres
JJJosé Roberto Jardim
José Roberto Jardim
OBJECTIVE: To identify and characterize alterations seen on HRCT scans in nonsmoking females with COPD due to wood smoke exposure. METHODS: We evaluated 42 nonsmoking females diagnosed with wood smoke-related COPD and 31 nonsmoking controls with no history of wood smoke exposure or pulmonary disease. The participants completed a questionnaire regarding demographic data, symptoms, and environmental exposure. All of the participants underwent spirometry and HRCT of the chest. The COPD and control groups were adjusted for age (23 patients each). RESULTS: Most of the patients in the study group were diagnosed with mild to moderate COPD (83.3%). The most common findings on HRCT scans in the COPD group were bronchial wall thickening, bronchiectasis, mosaic perfusion pattern, parenchymal bands, tree-in-bud pattern, and laminar atelectasis (p < 0.001 vs. the control group for all). The alterations were generally mild and not extensive. There was a positive association between bronchial wall thickening and hour-years of wood smoke exposure. Centrilobular emphysema was uncommon, and its occurrence did not differ between the groups (p = 0.232). CONCLUSIONS: Wood smoke exposure causes predominantly bronchial changes, which can be detected by HRCT, even in patients with mild COPD.

18 October 2018 in Radiologia Brasileira
Verified
Journal Article
Open access
PDF file
PTPedro Paulo Teixeira e Silva Torres
Pedro Paulo Teixeira e Silva Torres
MRMarcelo Fouad Rabahi
Marcelo Fouad Rabahi
MMMaria Auxiliadora Carmo Moreira
Maria Auxiliadora Carmo Moreira
PSPablo Rydz Pinheiro Santana
Pablo Rydz Pinheiro Santana
AGAntônio Carlos Portugal Gomes
Antônio Carlos Portugal Gomes
EMEdson Marchiori
Edson Marchiori
Pulmonary fungal infections, which can be opportunistic or endemic, lead to considerable morbidity and mortality. Such infections have multiple clinical presentations and imaging patterns, overlapping with those of various other diseases, complicating the diagnostic approach. Given the immensity of Brazil, knowledge of the epidemiological context of pulmonary fungal infections in the various regions of the country is paramount when considering their differential diagnoses. In addition, defining the patient immunological status will facilitate the identification of opportunistic infections, such as those occurring in patients with AIDS or febrile neutropenia. Histoplasmosis, coccidioidomycosis, and paracoccidioidomycosis usually affect immunocompetent patients, whereas aspergillosis, candidiasis, cryptococcosis, and pneumocystosis tend to affect those who are immunocompromised. Ground-glass opacities, nodules, consolidations, a miliary pattern, cavitary lesions, the halo sign/reversed halo sign, and bronchiectasis are typical imaging patterns in the lungs and will be described individually, as will less common lesions such as pleural effusion, mediastinal lesions, pleural effusion, and chest wall involvement. Interpreting such tomographic patterns/signs on computed tomography scans together with the patient immunological status and epidemiological context can facilitate the differential diagnosis by narrowing the options.

27 February 2024 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
LPLuiz Fernando Ferreira Pereira
Luiz Fernando Ferreira Pereira
RSRicardo Sales Dos Santos
Ricardo Sales Dos Santos
DBDaniel Oliveira Bonomi
Daniel Oliveira Bonomi
JFJuliana Franceschini
Juliana Franceschini
ISIlka Lopes Santoro
Ilka Lopes Santoro
WBWanderley Bernardo
Wanderley Bernardo
Although lung cancer (LC) is one of the most common and lethal tumors, only 15% of patients are diagnosed at an early stage. Smoking is still responsible for more than 85% of cases. Lung cancer screening (LCS) with low-dose CT (LDCT) reduces LC-related mortality by 20%, and that reduction reaches 38% when LCS by LDCT is combined with smoking cessation. In the last decade, a number of countries have adopted population-based LCS as a public health recommendation. Albeit still incipient, discussion on this topic in Brazil is becoming increasingly broad and necessary. With the aim of increasing knowledge and stimulating debate on LCS, the Brazilian Society of Thoracic Surgery, the Brazilian Thoracic Association, and the Brazilian College of Radiology and Diagnostic Imaging convened a panel of experts to prepare recommendations for LCS in Brazil. The recommendations presented here were based on a narrative review of the literature, with an emphasis on large population-based studies, systematic reviews, and the recommendations of international guidelines, and were developed after extensive discussion by the panel of experts. The following topics were reviewed: reasons for screening; general considerations about smoking; epidemiology of LC; eligibility criteria; incidental findings; granulomatous lesions; probabilistic models; minimum requirements for LDCT; volumetric acquisition; risks of screening; minimum structure and role of the multidisciplinary team; practice according to the Lung CT Screening Reporting and Data System; costs versus benefits of screening; and future perspectives for LCS.

21 January 2020 in British Journal of Radiology
Verified
Journal Article
Closed access
PTPedro Paulo Teixeira e Silva Torres
Pedro Paulo Teixeira e Silva Torres
AMAlexandre Dias Mançano
Alexandre Dias Mançano
GZGláucia Zanetti
Gláucia Zanetti
BHBruno Hochhegger
Bruno Hochhegger
AAAna Caroline Vieira Aurione
Ana Caroline Vieira Aurione
EMEdson Santos Marchiori
Edson Santos Marchiori
The clinical diagnosis of pulmonary embolism is often difficult, as symptoms range from syncope and chest pain to shock and sudden death. Adding complexity to this picture, some patients with non-diagnosed pulmonary embolism may undergo unenhanced imaging examinations for a number of reasons, including the prevention of contrast medium-related nephrotoxicity, anaphylactic/anaphylactoid reactions and nephrogenic systemic fibrosis, as well as due to patients’ refusal or lack of venous access. In this context, radiologists’ awareness and recognition of indirect signs are cornerstones in the diagnosis of pulmonary embolism. This article describes the indirect signs of pulmonary embolism on chest X-ray, unenhanced CT, and MRI.